nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—CYP2D6—Niacin—atherosclerosis	0.0578	0.169	CbGbCtD
Pergolide—CYP2D6—Simvastatin—atherosclerosis	0.0457	0.134	CbGbCtD
Pergolide—CYP2D6—Lovastatin—atherosclerosis	0.0447	0.131	CbGbCtD
Pergolide—CYP2D6—Pravastatin—atherosclerosis	0.0447	0.131	CbGbCtD
Pergolide—CYP3A4—Ezetimibe—atherosclerosis	0.0313	0.0916	CbGbCtD
Pergolide—CYP3A4—Rosuvastatin—atherosclerosis	0.0313	0.0916	CbGbCtD
Pergolide—CYP3A4—Simvastatin—atherosclerosis	0.0291	0.0851	CbGbCtD
Pergolide—CYP3A4—Lovastatin—atherosclerosis	0.0284	0.0833	CbGbCtD
Pergolide—CYP3A4—Pravastatin—atherosclerosis	0.0284	0.0833	CbGbCtD
Pergolide—HTR2A—arteriole—atherosclerosis	0.00529	0.145	CbGeAlD
Pergolide—HTR2A—vein—atherosclerosis	0.00315	0.0866	CbGeAlD
Pergolide—HTR1B—artery—atherosclerosis	0.00267	0.0733	CbGeAlD
Pergolide—HTR1D—artery—atherosclerosis	0.00258	0.071	CbGeAlD
Pergolide—HTR2A—hindlimb—atherosclerosis	0.00209	0.0575	CbGeAlD
Pergolide—HTR1B—blood vessel—atherosclerosis	0.00208	0.0571	CbGeAlD
Pergolide—HTR1D—blood vessel—atherosclerosis	0.00201	0.0553	CbGeAlD
Pergolide—HTR2A—appendage—atherosclerosis	0.0018	0.0493	CbGeAlD
Pergolide—HTR2A—artery—atherosclerosis	0.00128	0.0353	CbGeAlD
Pergolide—HTR2A—endothelium—atherosclerosis	0.00108	0.0298	CbGeAlD
Pergolide—HTR1D—connective tissue—atherosclerosis	0.00103	0.0283	CbGeAlD
Pergolide—HTR2A—blood vessel—atherosclerosis	0.001	0.0275	CbGeAlD
Pergolide—HTR1B—cardiovascular system—atherosclerosis	0.000928	0.0255	CbGeAlD
Pergolide—HTR1D—cardiovascular system—atherosclerosis	0.000898	0.0247	CbGeAlD
Pergolide—HTR2B—cardiovascular system—atherosclerosis	0.000836	0.0229	CbGeAlD
Pergolide—Jaundice—Niacin—atherosclerosis	0.000799	0.0022	CcSEcCtD
Pergolide—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000795	0.00219	CcSEcCtD
Pergolide—Myocardial infarction—Pravastatin—atherosclerosis	0.000791	0.00218	CcSEcCtD
Pergolide—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000791	0.00218	CcSEcCtD
Pergolide—Jaundice—Pravastatin—atherosclerosis	0.000786	0.00216	CcSEcCtD
Pergolide—Sweating—Niacin—atherosclerosis	0.000786	0.00216	CcSEcCtD
Pergolide—Urinary tract infection—Pravastatin—atherosclerosis	0.000784	0.00216	CcSEcCtD
Pergolide—Chills—Lovastatin—atherosclerosis	0.000768	0.00211	CcSEcCtD
Pergolide—Cough—Rosuvastatin—atherosclerosis	0.000768	0.00211	CcSEcCtD
Pergolide—Sinusitis—Pravastatin—atherosclerosis	0.000757	0.00208	CcSEcCtD
Pergolide—Alopecia—Lovastatin—atherosclerosis	0.000757	0.00208	CcSEcCtD
Pergolide—Arthralgia—Rosuvastatin—atherosclerosis	0.000749	0.00206	CcSEcCtD
Pergolide—Myalgia—Rosuvastatin—atherosclerosis	0.000749	0.00206	CcSEcCtD
Pergolide—HTR1A—cardiovascular system—atherosclerosis	0.000749	0.0206	CbGeAlD
Pergolide—Alopecia—Ezetimibe—atherosclerosis	0.000742	0.00204	CcSEcCtD
Pergolide—Rhinitis—Niacin—atherosclerosis	0.000737	0.00203	CcSEcCtD
Pergolide—HTR2B—adipose tissue—atherosclerosis	0.000737	0.0202	CbGeAlD
Pergolide—Hepatitis—Niacin—atherosclerosis	0.000736	0.00202	CcSEcCtD
Pergolide—Flatulence—Lovastatin—atherosclerosis	0.000735	0.00202	CcSEcCtD
Pergolide—Dysgeusia—Lovastatin—atherosclerosis	0.00073	0.00201	CcSEcCtD
Pergolide—Rhinitis—Pravastatin—atherosclerosis	0.000726	0.002	CcSEcCtD
Pergolide—Oedema peripheral—Niacin—atherosclerosis	0.000725	0.00199	CcSEcCtD
Pergolide—Hepatitis—Pravastatin—atherosclerosis	0.000724	0.00199	CcSEcCtD
Pergolide—Confusional state—Rosuvastatin—atherosclerosis	0.000724	0.00199	CcSEcCtD
Pergolide—Back pain—Lovastatin—atherosclerosis	0.000721	0.00198	CcSEcCtD
Pergolide—Flatulence—Ezetimibe—atherosclerosis	0.000721	0.00198	CcSEcCtD
Pergolide—Pharyngitis—Pravastatin—atherosclerosis	0.000719	0.00198	CcSEcCtD
Pergolide—Chills—Simvastatin—atherosclerosis	0.000719	0.00198	CcSEcCtD
Pergolide—Infection—Rosuvastatin—atherosclerosis	0.000713	0.00196	CcSEcCtD
Pergolide—Visual impairment—Niacin—atherosclerosis	0.000709	0.00195	CcSEcCtD
Pergolide—Alopecia—Simvastatin—atherosclerosis	0.000708	0.00195	CcSEcCtD
Pergolide—Back pain—Ezetimibe—atherosclerosis	0.000707	0.00195	CcSEcCtD
Pergolide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000703	0.00193	CcSEcCtD
Pergolide—Tremor—Lovastatin—atherosclerosis	0.000699	0.00192	CcSEcCtD
Pergolide—Visual impairment—Pravastatin—atherosclerosis	0.000698	0.00192	CcSEcCtD
Pergolide—Ill-defined disorder—Lovastatin—atherosclerosis	0.000692	0.0019	CcSEcCtD
Pergolide—ADRA1A—cardiovascular system—atherosclerosis	0.00069	0.019	CbGeAlD
Pergolide—Eye disorder—Niacin—atherosclerosis	0.000687	0.00189	CcSEcCtD
Pergolide—Flatulence—Simvastatin—atherosclerosis	0.000687	0.00189	CcSEcCtD
Pergolide—Tinnitus—Niacin—atherosclerosis	0.000686	0.00189	CcSEcCtD
Pergolide—Dysgeusia—Simvastatin—atherosclerosis	0.000683	0.00188	CcSEcCtD
Pergolide—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000679	0.00187	CcSEcCtD
Pergolide—Anaemia—Ezetimibe—atherosclerosis	0.000676	0.00186	CcSEcCtD
Pergolide—Tinnitus—Pravastatin—atherosclerosis	0.000675	0.00186	CcSEcCtD
Pergolide—Malaise—Lovastatin—atherosclerosis	0.000672	0.00185	CcSEcCtD
Pergolide—Vertigo—Lovastatin—atherosclerosis	0.00067	0.00184	CcSEcCtD
Pergolide—Leukopenia—Lovastatin—atherosclerosis	0.000667	0.00184	CcSEcCtD
Pergolide—KCNH2—cardiovascular system—atherosclerosis	0.000667	0.0183	CbGeAlD
Pergolide—Chills—Niacin—atherosclerosis	0.00066	0.00182	CcSEcCtD
Pergolide—Malaise—Ezetimibe—atherosclerosis	0.000659	0.00181	CcSEcCtD
Pergolide—Arrhythmia—Niacin—atherosclerosis	0.000657	0.00181	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000654	0.0018	CcSEcCtD
Pergolide—Tremor—Simvastatin—atherosclerosis	0.000653	0.0018	CcSEcCtD
Pergolide—Alopecia—Niacin—atherosclerosis	0.00065	0.00179	CcSEcCtD
Pergolide—Chills—Pravastatin—atherosclerosis	0.00065	0.00179	CcSEcCtD
Pergolide—Insomnia—Rosuvastatin—atherosclerosis	0.000649	0.00179	CcSEcCtD
Pergolide—Ill-defined disorder—Simvastatin—atherosclerosis	0.000647	0.00178	CcSEcCtD
Pergolide—Arrhythmia—Pravastatin—atherosclerosis	0.000647	0.00178	CcSEcCtD
Pergolide—Palpitations—Ezetimibe—atherosclerosis	0.000646	0.00178	CcSEcCtD
Pergolide—Paraesthesia—Rosuvastatin—atherosclerosis	0.000645	0.00177	CcSEcCtD
Pergolide—Anaemia—Simvastatin—atherosclerosis	0.000645	0.00177	CcSEcCtD
Pergolide—Alopecia—Pravastatin—atherosclerosis	0.00064	0.00176	CcSEcCtD
Pergolide—Cough—Ezetimibe—atherosclerosis	0.000638	0.00176	CcSEcCtD
Pergolide—Myalgia—Lovastatin—atherosclerosis	0.000635	0.00175	CcSEcCtD
Pergolide—Chest pain—Lovastatin—atherosclerosis	0.000635	0.00175	CcSEcCtD
Pergolide—Arthralgia—Lovastatin—atherosclerosis	0.000635	0.00175	CcSEcCtD
Pergolide—Anxiety—Lovastatin—atherosclerosis	0.000633	0.00174	CcSEcCtD
Pergolide—Dyspepsia—Rosuvastatin—atherosclerosis	0.000632	0.00174	CcSEcCtD
Pergolide—Hypertension—Ezetimibe—atherosclerosis	0.000631	0.00174	CcSEcCtD
Pergolide—Flatulence—Niacin—atherosclerosis	0.000631	0.00174	CcSEcCtD
Pergolide—Malaise—Simvastatin—atherosclerosis	0.000629	0.00173	CcSEcCtD
Pergolide—Tension—Niacin—atherosclerosis	0.000628	0.00173	CcSEcCtD
Pergolide—Discomfort—Lovastatin—atherosclerosis	0.000627	0.00173	CcSEcCtD
Pergolide—Vertigo—Simvastatin—atherosclerosis	0.000627	0.00172	CcSEcCtD
Pergolide—Leukopenia—Simvastatin—atherosclerosis	0.000624	0.00172	CcSEcCtD
Pergolide—Arthralgia—Ezetimibe—atherosclerosis	0.000623	0.00171	CcSEcCtD
Pergolide—Myalgia—Ezetimibe—atherosclerosis	0.000623	0.00171	CcSEcCtD
Pergolide—Chest pain—Ezetimibe—atherosclerosis	0.000623	0.00171	CcSEcCtD
Pergolide—Nervousness—Niacin—atherosclerosis	0.000622	0.00171	CcSEcCtD
Pergolide—Flatulence—Pravastatin—atherosclerosis	0.000621	0.00171	CcSEcCtD
Pergolide—Dry mouth—Lovastatin—atherosclerosis	0.000621	0.00171	CcSEcCtD
Pergolide—Tension—Pravastatin—atherosclerosis	0.000619	0.0017	CcSEcCtD
Pergolide—Dysgeusia—Pravastatin—atherosclerosis	0.000617	0.0017	CcSEcCtD
Pergolide—Discomfort—Ezetimibe—atherosclerosis	0.000615	0.00169	CcSEcCtD
Pergolide—Pain—Rosuvastatin—atherosclerosis	0.000614	0.00169	CcSEcCtD
Pergolide—Constipation—Rosuvastatin—atherosclerosis	0.000614	0.00169	CcSEcCtD
Pergolide—Confusional state—Lovastatin—atherosclerosis	0.000614	0.00169	CcSEcCtD
Pergolide—Nervousness—Pravastatin—atherosclerosis	0.000612	0.00169	CcSEcCtD
Pergolide—Dry mouth—Ezetimibe—atherosclerosis	0.000609	0.00168	CcSEcCtD
Pergolide—ADRA1A—adipose tissue—atherosclerosis	0.000609	0.0167	CbGeAlD
Pergolide—Infection—Lovastatin—atherosclerosis	0.000605	0.00166	CcSEcCtD
Pergolide—ADRA2A—connective tissue—atherosclerosis	0.000603	0.0166	CbGeAlD
Pergolide—Confusional state—Ezetimibe—atherosclerosis	0.000602	0.00166	CcSEcCtD
Pergolide—Thrombocytopenia—Lovastatin—atherosclerosis	0.000596	0.00164	CcSEcCtD
Pergolide—Arthralgia—Simvastatin—atherosclerosis	0.000594	0.00163	CcSEcCtD
Pergolide—Chest pain—Simvastatin—atherosclerosis	0.000594	0.00163	CcSEcCtD
Pergolide—Myalgia—Simvastatin—atherosclerosis	0.000594	0.00163	CcSEcCtD
Pergolide—Infection—Ezetimibe—atherosclerosis	0.000593	0.00163	CcSEcCtD
Pergolide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000592	0.00163	CcSEcCtD
Pergolide—Anxiety—Simvastatin—atherosclerosis	0.000592	0.00163	CcSEcCtD
Pergolide—Tremor—Pravastatin—atherosclerosis	0.000591	0.00163	CcSEcCtD
Pergolide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000587	0.00162	CcSEcCtD
Pergolide—Discomfort—Simvastatin—atherosclerosis	0.000587	0.00161	CcSEcCtD
Pergolide—Ill-defined disorder—Pravastatin—atherosclerosis	0.000585	0.00161	CcSEcCtD
Pergolide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000584	0.00161	CcSEcCtD
Pergolide—Anaemia—Pravastatin—atherosclerosis	0.000583	0.0016	CcSEcCtD
Pergolide—Anorexia—Lovastatin—atherosclerosis	0.00058	0.0016	CcSEcCtD
Pergolide—ADRA2C—adipose tissue—atherosclerosis	0.00058	0.0159	CbGeAlD
Pergolide—Vertigo—Niacin—atherosclerosis	0.000575	0.00158	CcSEcCtD
Pergolide—Syncope—Niacin—atherosclerosis	0.000574	0.00158	CcSEcCtD
Pergolide—Confusional state—Simvastatin—atherosclerosis	0.000574	0.00158	CcSEcCtD
Pergolide—Leukopenia—Niacin—atherosclerosis	0.000573	0.00158	CcSEcCtD
Pergolide—Oedema—Simvastatin—atherosclerosis	0.000569	0.00157	CcSEcCtD
Pergolide—Malaise—Pravastatin—atherosclerosis	0.000569	0.00156	CcSEcCtD
Pergolide—Abdominal pain—Rosuvastatin—atherosclerosis	0.000568	0.00156	CcSEcCtD
Pergolide—Vertigo—Pravastatin—atherosclerosis	0.000566	0.00156	CcSEcCtD
Pergolide—Palpitations—Niacin—atherosclerosis	0.000566	0.00156	CcSEcCtD
Pergolide—Infection—Simvastatin—atherosclerosis	0.000565	0.00156	CcSEcCtD
Pergolide—Leukopenia—Pravastatin—atherosclerosis	0.000564	0.00155	CcSEcCtD
Pergolide—Loss of consciousness—Niacin—atherosclerosis	0.000563	0.00155	CcSEcCtD
Pergolide—Cough—Niacin—atherosclerosis	0.000559	0.00154	CcSEcCtD
Pergolide—Thrombocytopenia—Simvastatin—atherosclerosis	0.000557	0.00153	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000554	0.00153	CcSEcCtD
Pergolide—Insomnia—Lovastatin—atherosclerosis	0.00055	0.00151	CcSEcCtD
Pergolide—Cough—Pravastatin—atherosclerosis	0.00055	0.00151	CcSEcCtD
Pergolide—Paraesthesia—Lovastatin—atherosclerosis	0.000546	0.0015	CcSEcCtD
Pergolide—Myalgia—Niacin—atherosclerosis	0.000545	0.0015	CcSEcCtD
Pergolide—Arthralgia—Niacin—atherosclerosis	0.000545	0.0015	CcSEcCtD
Pergolide—Hypertension—Pravastatin—atherosclerosis	0.000544	0.0015	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000544	0.0015	CcSEcCtD
Pergolide—Anorexia—Simvastatin—atherosclerosis	0.000543	0.00149	CcSEcCtD
Pergolide—Dyspnoea—Lovastatin—atherosclerosis	0.000542	0.00149	CcSEcCtD
Pergolide—Insomnia—Ezetimibe—atherosclerosis	0.00054	0.00149	CcSEcCtD
Pergolide—Arthralgia—Pravastatin—atherosclerosis	0.000537	0.00148	CcSEcCtD
Pergolide—Myalgia—Pravastatin—atherosclerosis	0.000537	0.00148	CcSEcCtD
Pergolide—Chest pain—Pravastatin—atherosclerosis	0.000537	0.00148	CcSEcCtD
Pergolide—Paraesthesia—Ezetimibe—atherosclerosis	0.000536	0.00147	CcSEcCtD
Pergolide—Dyspepsia—Lovastatin—atherosclerosis	0.000536	0.00147	CcSEcCtD
Pergolide—Anxiety—Pravastatin—atherosclerosis	0.000535	0.00147	CcSEcCtD
Pergolide—Dry mouth—Niacin—atherosclerosis	0.000533	0.00147	CcSEcCtD
Pergolide—Dyspnoea—Ezetimibe—atherosclerosis	0.000532	0.00146	CcSEcCtD
Pergolide—Discomfort—Pravastatin—atherosclerosis	0.00053	0.00146	CcSEcCtD
Pergolide—Decreased appetite—Lovastatin—atherosclerosis	0.000529	0.00146	CcSEcCtD
Pergolide—Dyspepsia—Ezetimibe—atherosclerosis	0.000525	0.00145	CcSEcCtD
Pergolide—Oedema—Niacin—atherosclerosis	0.000523	0.00144	CcSEcCtD
Pergolide—Pain—Lovastatin—atherosclerosis	0.00052	0.00143	CcSEcCtD
Pergolide—Constipation—Lovastatin—atherosclerosis	0.00052	0.00143	CcSEcCtD
Pergolide—Confusional state—Pravastatin—atherosclerosis	0.000519	0.00143	CcSEcCtD
Pergolide—Decreased appetite—Ezetimibe—atherosclerosis	0.000519	0.00143	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000519	0.00143	CcSEcCtD
Pergolide—Asthenia—Rosuvastatin—atherosclerosis	0.000515	0.00142	CcSEcCtD
Pergolide—Insomnia—Simvastatin—atherosclerosis	0.000515	0.00142	CcSEcCtD
Pergolide—Oedema—Pravastatin—atherosclerosis	0.000515	0.00142	CcSEcCtD
Pergolide—Shock—Niacin—atherosclerosis	0.000514	0.00142	CcSEcCtD
Pergolide—HTR2A—connective tissue—atherosclerosis	0.000513	0.0141	CbGeAlD
Pergolide—Infection—Pravastatin—atherosclerosis	0.000511	0.00141	CcSEcCtD
Pergolide—Paraesthesia—Simvastatin—atherosclerosis	0.000511	0.00141	CcSEcCtD
Pergolide—Pain—Ezetimibe—atherosclerosis	0.00051	0.0014	CcSEcCtD
Pergolide—Constipation—Ezetimibe—atherosclerosis	0.00051	0.0014	CcSEcCtD
Pergolide—Tachycardia—Niacin—atherosclerosis	0.00051	0.0014	CcSEcCtD
Pergolide—Pruritus—Rosuvastatin—atherosclerosis	0.000508	0.0014	CcSEcCtD
Pergolide—Dyspnoea—Simvastatin—atherosclerosis	0.000507	0.0014	CcSEcCtD
Pergolide—Hyperhidrosis—Niacin—atherosclerosis	0.000505	0.00139	CcSEcCtD
Pergolide—Thrombocytopenia—Pravastatin—atherosclerosis	0.000504	0.00139	CcSEcCtD
Pergolide—Feeling abnormal—Lovastatin—atherosclerosis	0.000501	0.00138	CcSEcCtD
Pergolide—Dyspepsia—Simvastatin—atherosclerosis	0.000501	0.00138	CcSEcCtD
Pergolide—Anorexia—Niacin—atherosclerosis	0.000498	0.00137	CcSEcCtD
Pergolide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000498	0.00137	CcSEcCtD
Pergolide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000497	0.00137	CcSEcCtD
Pergolide—Decreased appetite—Simvastatin—atherosclerosis	0.000495	0.00136	CcSEcCtD
Pergolide—Feeling abnormal—Ezetimibe—atherosclerosis	0.000492	0.00135	CcSEcCtD
Pergolide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000491	0.00135	CcSEcCtD
Pergolide—Anorexia—Pravastatin—atherosclerosis	0.00049	0.00135	CcSEcCtD
Pergolide—Hypotension—Niacin—atherosclerosis	0.000488	0.00134	CcSEcCtD
Pergolide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000488	0.00134	CcSEcCtD
Pergolide—Constipation—Simvastatin—atherosclerosis	0.000487	0.00134	CcSEcCtD
Pergolide—Pain—Simvastatin—atherosclerosis	0.000487	0.00134	CcSEcCtD
Pergolide—Body temperature increased—Lovastatin—atherosclerosis	0.000481	0.00132	CcSEcCtD
Pergolide—Abdominal pain—Lovastatin—atherosclerosis	0.000481	0.00132	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000476	0.00131	CcSEcCtD
Pergolide—Dizziness—Rosuvastatin—atherosclerosis	0.000475	0.00131	CcSEcCtD
Pergolide—Insomnia—Niacin—atherosclerosis	0.000473	0.0013	CcSEcCtD
Pergolide—Abdominal pain—Ezetimibe—atherosclerosis	0.000472	0.0013	CcSEcCtD
Pergolide—Body temperature increased—Ezetimibe—atherosclerosis	0.000472	0.0013	CcSEcCtD
Pergolide—Paraesthesia—Niacin—atherosclerosis	0.000469	0.00129	CcSEcCtD
Pergolide—Feeling abnormal—Simvastatin—atherosclerosis	0.000469	0.00129	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000469	0.00129	CcSEcCtD
Pergolide—Dyspnoea—Niacin—atherosclerosis	0.000466	0.00128	CcSEcCtD
Pergolide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000465	0.00128	CcSEcCtD
Pergolide—Insomnia—Pravastatin—atherosclerosis	0.000465	0.00128	CcSEcCtD
Pergolide—Somnolence—Niacin—atherosclerosis	0.000465	0.00128	CcSEcCtD
Pergolide—ADRA2A—adipose tissue—atherosclerosis	0.000463	0.0127	CbGeAlD
Pergolide—Paraesthesia—Pravastatin—atherosclerosis	0.000462	0.00127	CcSEcCtD
Pergolide—Dyspepsia—Niacin—atherosclerosis	0.00046	0.00127	CcSEcCtD
Pergolide—Dyspnoea—Pravastatin—atherosclerosis	0.000459	0.00126	CcSEcCtD
Pergolide—Decreased appetite—Niacin—atherosclerosis	0.000454	0.00125	CcSEcCtD
Pergolide—Dyspepsia—Pravastatin—atherosclerosis	0.000453	0.00125	CcSEcCtD
Pergolide—Rash—Rosuvastatin—atherosclerosis	0.000453	0.00125	CcSEcCtD
Pergolide—Dermatitis—Rosuvastatin—atherosclerosis	0.000452	0.00124	CcSEcCtD
Pergolide—Abdominal pain—Simvastatin—atherosclerosis	0.00045	0.00124	CcSEcCtD
Pergolide—Body temperature increased—Simvastatin—atherosclerosis	0.00045	0.00124	CcSEcCtD
Pergolide—Headache—Rosuvastatin—atherosclerosis	0.00045	0.00124	CcSEcCtD
Pergolide—Decreased appetite—Pravastatin—atherosclerosis	0.000447	0.00123	CcSEcCtD
Pergolide—Pain—Niacin—atherosclerosis	0.000447	0.00123	CcSEcCtD
Pergolide—HTR2A—cardiovascular system—atherosclerosis	0.000446	0.0123	CbGeAlD
Pergolide—Pain—Pravastatin—atherosclerosis	0.00044	0.00121	CcSEcCtD
Pergolide—Constipation—Pravastatin—atherosclerosis	0.00044	0.00121	CcSEcCtD
Pergolide—Asthenia—Lovastatin—atherosclerosis	0.000437	0.0012	CcSEcCtD
Pergolide—Pruritus—Lovastatin—atherosclerosis	0.00043	0.00118	CcSEcCtD
Pergolide—Asthenia—Ezetimibe—atherosclerosis	0.000428	0.00118	CcSEcCtD
Pergolide—Gastrointestinal pain—Niacin—atherosclerosis	0.000427	0.00118	CcSEcCtD
Pergolide—ADRA1A—liver—atherosclerosis	0.000427	0.0117	CbGeAlD
Pergolide—Nausea—Rosuvastatin—atherosclerosis	0.000426	0.00117	CcSEcCtD
Pergolide—Feeling abnormal—Pravastatin—atherosclerosis	0.000424	0.00117	CcSEcCtD
Pergolide—Pruritus—Ezetimibe—atherosclerosis	0.000422	0.00116	CcSEcCtD
Pergolide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000421	0.00116	CcSEcCtD
Pergolide—Diarrhoea—Lovastatin—atherosclerosis	0.000416	0.00115	CcSEcCtD
Pergolide—Abdominal pain—Niacin—atherosclerosis	0.000413	0.00114	CcSEcCtD
Pergolide—Body temperature increased—Niacin—atherosclerosis	0.000413	0.00114	CcSEcCtD
Pergolide—Asthenia—Simvastatin—atherosclerosis	0.000408	0.00112	CcSEcCtD
Pergolide—Diarrhoea—Ezetimibe—atherosclerosis	0.000408	0.00112	CcSEcCtD
Pergolide—Abdominal pain—Pravastatin—atherosclerosis	0.000407	0.00112	CcSEcCtD
Pergolide—Body temperature increased—Pravastatin—atherosclerosis	0.000407	0.00112	CcSEcCtD
Pergolide—ADRA2C—liver—atherosclerosis	0.000407	0.0112	CbGeAlD
Pergolide—Pruritus—Simvastatin—atherosclerosis	0.000403	0.00111	CcSEcCtD
Pergolide—Dizziness—Lovastatin—atherosclerosis	0.000402	0.00111	CcSEcCtD
Pergolide—Dizziness—Ezetimibe—atherosclerosis	0.000395	0.00109	CcSEcCtD
Pergolide—Diarrhoea—Simvastatin—atherosclerosis	0.000389	0.00107	CcSEcCtD
Pergolide—Vomiting—Lovastatin—atherosclerosis	0.000387	0.00106	CcSEcCtD
Pergolide—Rash—Lovastatin—atherosclerosis	0.000384	0.00106	CcSEcCtD
Pergolide—Dermatitis—Lovastatin—atherosclerosis	0.000383	0.00105	CcSEcCtD
Pergolide—Headache—Lovastatin—atherosclerosis	0.000381	0.00105	CcSEcCtD
Pergolide—Vomiting—Ezetimibe—atherosclerosis	0.000379	0.00104	CcSEcCtD
Pergolide—Dizziness—Simvastatin—atherosclerosis	0.000376	0.00104	CcSEcCtD
Pergolide—Rash—Ezetimibe—atherosclerosis	0.000376	0.00104	CcSEcCtD
Pergolide—Dermatitis—Ezetimibe—atherosclerosis	0.000376	0.00103	CcSEcCtD
Pergolide—Asthenia—Niacin—atherosclerosis	0.000375	0.00103	CcSEcCtD
Pergolide—Headache—Ezetimibe—atherosclerosis	0.000374	0.00103	CcSEcCtD
Pergolide—Pruritus—Niacin—atherosclerosis	0.00037	0.00102	CcSEcCtD
Pergolide—Asthenia—Pravastatin—atherosclerosis	0.000369	0.00102	CcSEcCtD
Pergolide—Pruritus—Pravastatin—atherosclerosis	0.000364	0.001	CcSEcCtD
Pergolide—Vomiting—Simvastatin—atherosclerosis	0.000362	0.000996	CcSEcCtD
Pergolide—Nausea—Lovastatin—atherosclerosis	0.000361	0.000995	CcSEcCtD
Pergolide—Rash—Simvastatin—atherosclerosis	0.000359	0.000988	CcSEcCtD
Pergolide—Dermatitis—Simvastatin—atherosclerosis	0.000359	0.000987	CcSEcCtD
Pergolide—Diarrhoea—Niacin—atherosclerosis	0.000358	0.000984	CcSEcCtD
Pergolide—Headache—Simvastatin—atherosclerosis	0.000357	0.000981	CcSEcCtD
Pergolide—Nausea—Ezetimibe—atherosclerosis	0.000355	0.000976	CcSEcCtD
Pergolide—Diarrhoea—Pravastatin—atherosclerosis	0.000352	0.000969	CcSEcCtD
Pergolide—Dizziness—Niacin—atherosclerosis	0.000346	0.000951	CcSEcCtD
Pergolide—Dizziness—Pravastatin—atherosclerosis	0.00034	0.000936	CcSEcCtD
Pergolide—Nausea—Simvastatin—atherosclerosis	0.000338	0.00093	CcSEcCtD
Pergolide—Vomiting—Niacin—atherosclerosis	0.000332	0.000914	CcSEcCtD
Pergolide—Rash—Niacin—atherosclerosis	0.00033	0.000907	CcSEcCtD
Pergolide—Dermatitis—Niacin—atherosclerosis	0.000329	0.000906	CcSEcCtD
Pergolide—Headache—Niacin—atherosclerosis	0.000327	0.000901	CcSEcCtD
Pergolide—Vomiting—Pravastatin—atherosclerosis	0.000327	0.0009	CcSEcCtD
Pergolide—Rash—Pravastatin—atherosclerosis	0.000324	0.000893	CcSEcCtD
Pergolide—Dermatitis—Pravastatin—atherosclerosis	0.000324	0.000892	CcSEcCtD
Pergolide—Headache—Pravastatin—atherosclerosis	0.000322	0.000887	CcSEcCtD
Pergolide—Nausea—Niacin—atherosclerosis	0.00031	0.000854	CcSEcCtD
Pergolide—Nausea—Pravastatin—atherosclerosis	0.000306	0.000841	CcSEcCtD
Pergolide—HTR2A—liver—atherosclerosis	0.000276	0.00758	CbGeAlD
Pergolide—CYP3A4—liver—atherosclerosis	0.000255	0.00701	CbGeAlD
Pergolide—CYP2D6—liver—atherosclerosis	0.000251	0.0069	CbGeAlD
Pergolide—HTR2B—Signaling Pathways—MMP9—atherosclerosis	9.69e-06	3.74e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—F2—atherosclerosis	9.69e-06	3.74e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—INS—atherosclerosis	9.65e-06	3.73e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CCL2—atherosclerosis	9.65e-06	3.73e-05	CbGpPWpGaD
Pergolide—ADRA1D—GPCR downstream signaling—AKT1—atherosclerosis	9.63e-06	3.72e-05	CbGpPWpGaD
Pergolide—DRD3—GPCR downstream signaling—AKT1—atherosclerosis	9.63e-06	3.72e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—ALB—atherosclerosis	9.62e-06	3.72e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—IL6—atherosclerosis	9.61e-06	3.71e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—NFKB1—atherosclerosis	9.59e-06	3.7e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	9.56e-06	3.69e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—LPL—atherosclerosis	9.55e-06	3.69e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CCL2—atherosclerosis	9.49e-06	3.67e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IGF1—atherosclerosis	9.48e-06	3.66e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—IL6—atherosclerosis	9.48e-06	3.66e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—IL6—atherosclerosis	9.48e-06	3.66e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—NOS3—atherosclerosis	9.48e-06	3.66e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—VEGFA—atherosclerosis	9.46e-06	3.65e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—SCARB1—atherosclerosis	9.45e-06	3.65e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—INS—atherosclerosis	9.45e-06	3.65e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MAPK8—atherosclerosis	9.42e-06	3.64e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—AKT1—atherosclerosis	9.4e-06	3.63e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—STAT3—atherosclerosis	9.37e-06	3.62e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IGF1—atherosclerosis	9.33e-06	3.6e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	9.33e-06	3.6e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—GPX1—atherosclerosis	9.32e-06	3.6e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	9.29e-06	3.59e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	9.27e-06	3.58e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—VEGFA—atherosclerosis	9.26e-06	3.58e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—NOS3—atherosclerosis	9.2e-06	3.56e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—STAT3—atherosclerosis	9.17e-06	3.54e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	9.14e-06	3.53e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MMP9—atherosclerosis	9.14e-06	3.53e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—VEGFA—atherosclerosis	9.11e-06	3.52e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CD36—atherosclerosis	9.08e-06	3.51e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—NFKB1—atherosclerosis	9.04e-06	3.49e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—STAT3—atherosclerosis	9.02e-06	3.49e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MMP9—atherosclerosis	9.02e-06	3.48e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MMP9—atherosclerosis	9.02e-06	3.48e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	9.01e-06	3.48e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	9e-06	3.48e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—MAPK3—atherosclerosis	8.95e-06	3.46e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—HMGCR—atherosclerosis	8.93e-06	3.45e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—NFKB1—atherosclerosis	8.92e-06	3.44e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—NFKB1—atherosclerosis	8.92e-06	3.44e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MAPK8—atherosclerosis	8.89e-06	3.43e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	8.88e-06	3.43e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—AKT1—atherosclerosis	8.86e-06	3.42e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—SERPINE1—atherosclerosis	8.86e-06	3.42e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—INS—atherosclerosis	8.78e-06	3.39e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MAPK8—atherosclerosis	8.77e-06	3.39e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MAPK8—atherosclerosis	8.77e-06	3.39e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—MAPK3—atherosclerosis	8.76e-06	3.38e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—AKT1—atherosclerosis	8.74e-06	3.38e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—AKT1—atherosclerosis	8.74e-06	3.38e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—VEGFA—atherosclerosis	8.7e-06	3.36e-05	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	8.69e-06	3.36e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	8.69e-06	3.35e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TGFB1—atherosclerosis	8.68e-06	3.35e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	8.68e-06	3.35e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CXCL8—atherosclerosis	8.64e-06	3.34e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	8.64e-06	3.34e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—MAPK3—atherosclerosis	8.62e-06	3.33e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—STAT3—atherosclerosis	8.61e-06	3.33e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—MTHFR—atherosclerosis	8.6e-06	3.32e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—NOS3—atherosclerosis	8.6e-06	3.32e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	8.56e-06	3.3e-05	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—IL6—atherosclerosis	8.54e-06	3.3e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TGFB1—atherosclerosis	8.5e-06	3.28e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	8.49e-06	3.28e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—NOS3—atherosclerosis	8.46e-06	3.27e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PPARA—atherosclerosis	8.44e-06	3.26e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PTGS2—atherosclerosis	8.42e-06	3.25e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CXCL8—atherosclerosis	8.41e-06	3.25e-05	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	8.39e-06	3.24e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TGFB1—atherosclerosis	8.36e-06	3.23e-05	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	8.35e-06	3.22e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	8.28e-06	3.2e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	8.27e-06	3.19e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—IL6—atherosclerosis	8.26e-06	3.19e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MAPK3—atherosclerosis	8.23e-06	3.18e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—IL6—atherosclerosis	8.22e-06	3.17e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—VEGFA—atherosclerosis	8.2e-06	3.17e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—AGT—atherosclerosis	8.17e-06	3.16e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	8.14e-06	3.14e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—STAT3—atherosclerosis	8.12e-06	3.14e-05	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	8.12e-06	3.14e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—VEGFA—atherosclerosis	8.1e-06	3.13e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	8.1e-06	3.13e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	8.06e-06	3.11e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	8.05e-06	3.11e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	8.02e-06	3.1e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—STAT3—atherosclerosis	8.02e-06	3.1e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—APOE—atherosclerosis	8.01e-06	3.09e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	7.99e-06	3.09e-05	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	7.99e-06	3.09e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TGFB1—atherosclerosis	7.99e-06	3.08e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ABCA1—atherosclerosis	7.96e-06	3.07e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CAV1—atherosclerosis	7.93e-06	3.06e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	7.92e-06	3.06e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—APOA1—atherosclerosis	7.91e-06	3.06e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	7.89e-06	3.05e-05	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—AKT1—atherosclerosis	7.88e-06	3.04e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	7.87e-06	3.04e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MMP9—atherosclerosis	7.86e-06	3.03e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MMP9—atherosclerosis	7.82e-06	3.02e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	7.77e-06	3e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MAPK3—atherosclerosis	7.76e-06	3e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	7.73e-06	2.99e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	7.7e-06	2.97e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MAPK3—atherosclerosis	7.66e-06	2.96e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	7.66e-06	2.96e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	7.64e-06	2.95e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CXCL8—atherosclerosis	7.63e-06	2.95e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	7.62e-06	2.94e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	7.6e-06	2.94e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	7.6e-06	2.94e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	7.58e-06	2.93e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TGFB1—atherosclerosis	7.53e-06	2.91e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	7.52e-06	2.91e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	7.5e-06	2.9e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	7.48e-06	2.89e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	7.43e-06	2.87e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TGFB1—atherosclerosis	7.43e-06	2.87e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	7.4e-06	2.86e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	7.39e-06	2.86e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	7.37e-06	2.85e-05	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	7.37e-06	2.85e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	7.35e-06	2.84e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	7.31e-06	2.82e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	7.28e-06	2.81e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	7.26e-06	2.8e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—IL6—atherosclerosis	7.25e-06	2.8e-05	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	7.25e-06	2.8e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	7.24e-06	2.79e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3CG—atherosclerosis	7.23e-06	2.79e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—IL6—atherosclerosis	7.14e-06	2.76e-05	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	7.1e-06	2.74e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	7.06e-06	2.72e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	7.02e-06	2.71e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	6.99e-06	2.7e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—STAT3—atherosclerosis	6.99e-06	2.7e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PPARG—atherosclerosis	6.97e-06	2.69e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—STAT3—atherosclerosis	6.95e-06	2.68e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	6.91e-06	2.67e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MMP9—atherosclerosis	6.9e-06	2.66e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—INS—atherosclerosis	6.84e-06	2.64e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—HMOX1—atherosclerosis	6.83e-06	2.64e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	6.83e-06	2.64e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	6.83e-06	2.64e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—NFKB1—atherosclerosis	6.83e-06	2.64e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MMP9—atherosclerosis	6.79e-06	2.62e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	6.76e-06	2.61e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	6.72e-06	2.59e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	6.72e-06	2.59e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MAPK8—atherosclerosis	6.71e-06	2.59e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	6.71e-06	2.59e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—AKT1—atherosclerosis	6.69e-06	2.58e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	6.67e-06	2.58e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	6.65e-06	2.57e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	6.65e-06	2.57e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	6.64e-06	2.56e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	6.6e-06	2.55e-05	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	6.6e-06	2.55e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	6.58e-06	2.54e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	6.58e-06	2.54e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IL6—atherosclerosis	6.54e-06	2.53e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—APOB—atherosclerosis	6.54e-06	2.53e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	6.49e-06	2.51e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	6.48e-06	2.5e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	6.46e-06	2.5e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	6.46e-06	2.49e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	6.45e-06	2.49e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	6.44e-06	2.49e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IL6—atherosclerosis	6.41e-06	2.47e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.36e-06	2.46e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	6.36e-06	2.45e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IL6—atherosclerosis	6.3e-06	2.43e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—ALB—atherosclerosis	6.27e-06	2.42e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	6.27e-06	2.42e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—LPL—atherosclerosis	6.24e-06	2.41e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—VEGFA—atherosclerosis	6.19e-06	2.39e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	6.18e-06	2.38e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	6.17e-06	2.38e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—STAT3—atherosclerosis	6.13e-06	2.37e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	6.11e-06	2.36e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	6.09e-06	2.35e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GPX1—atherosclerosis	6.09e-06	2.35e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—AKT1—atherosclerosis	6.03e-06	2.33e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—STAT3—atherosclerosis	6.03e-06	2.33e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IL6—atherosclerosis	6.02e-06	2.32e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	6.01e-06	2.32e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—NOS3—atherosclerosis	6e-06	2.32e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	5.99e-06	2.31e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	5.97e-06	2.3e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CD36—atherosclerosis	5.93e-06	2.29e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—AKT1—atherosclerosis	5.91e-06	2.28e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	5.91e-06	2.28e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MAPK3—atherosclerosis	5.86e-06	2.26e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—AKT1—atherosclerosis	5.81e-06	2.25e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	5.77e-06	2.23e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TGFB1—atherosclerosis	5.69e-06	2.2e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IL6—atherosclerosis	5.67e-06	2.19e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	5.65e-06	2.18e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.62e-06	2.17e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IL6—atherosclerosis	5.6e-06	2.16e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IL6—atherosclerosis	5.6e-06	2.16e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	5.59e-06	2.16e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—AKT1—atherosclerosis	5.55e-06	2.14e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	5.55e-06	2.14e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PPARA—atherosclerosis	5.52e-06	2.13e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	5.49e-06	2.12e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.49e-06	2.12e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	5.48e-06	2.12e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—AGT—atherosclerosis	5.34e-06	2.06e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	5.25e-06	2.03e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—AKT1—atherosclerosis	5.23e-06	2.02e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—APOE—atherosclerosis	5.23e-06	2.02e-05	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—AKT1—atherosclerosis	5.21e-06	2.01e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CAV1—atherosclerosis	5.19e-06	2e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—APOA1—atherosclerosis	5.17e-06	2e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	5.17e-06	1.99e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—AKT1—atherosclerosis	5.17e-06	1.99e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	5.09e-06	1.97e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IL6—atherosclerosis	5.05e-06	1.95e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL6—atherosclerosis	4.88e-06	1.88e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL6—atherosclerosis	4.85e-06	1.87e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.72e-06	1.82e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL6—atherosclerosis	4.72e-06	1.82e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	4.66e-06	1.8e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL6—atherosclerosis	4.65e-06	1.79e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PPARG—atherosclerosis	4.56e-06	1.76e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—AKT1—atherosclerosis	4.5e-06	1.74e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—AKT1—atherosclerosis	4.48e-06	1.73e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—INS—atherosclerosis	4.47e-06	1.73e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	4.36e-06	1.68e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	4.29e-06	1.66e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL6—atherosclerosis	4.28e-06	1.65e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—AKT1—atherosclerosis	4.23e-06	1.63e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL6—atherosclerosis	4.22e-06	1.63e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL6—atherosclerosis	4.13e-06	1.59e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ALB—atherosclerosis	4.1e-06	1.58e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—AKT1—atherosclerosis	3.95e-06	1.53e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—NOS3—atherosclerosis	3.92e-06	1.51e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—AKT1—atherosclerosis	3.89e-06	1.5e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL6—atherosclerosis	3.84e-06	1.48e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	3.81e-06	1.47e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.59e-06	1.39e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	3.54e-06	1.37e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—AKT1—atherosclerosis	2.76e-06	1.06e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—AKT1—atherosclerosis	1.8e-06	6.96e-06	CbGpPWpGaD
